Compare ALKS & DAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALKS | DAR |
|---|---|---|
| Founded | 1987 | 1882 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Packaged Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.7B | 9.7B |
| IPO Year | 2012 | 2002 |
| Metric | ALKS | DAR |
|---|---|---|
| Price | $52.26 | $63.60 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 11 |
| Target Price | $43.43 | ★ $65.82 |
| AVG Volume (30 Days) | 2.3M | ★ 2.4M |
| Earning Date | 05-05-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.83 |
| Revenue | $1,475,899,000.00 | ★ $6,135,877,000.00 |
| Revenue This Year | $24.26 | $7.78 |
| Revenue Next Year | $4.47 | $3.37 |
| P/E Ratio | ★ N/A | $76.51 |
| Revenue Growth | N/A | ★ 7.36 |
| 52 Week Low | $25.17 | $29.15 |
| 52 Week High | $55.67 | $66.02 |
| Indicator | ALKS | DAR |
|---|---|---|
| Relative Strength Index (RSI) | 59.70 | 68.50 |
| Support Level | $27.78 | $56.74 |
| Resistance Level | $55.67 | $63.95 |
| Average True Range (ATR) | 1.71 | 1.80 |
| MACD | -0.62 | 0.71 |
| Stochastic Oscillator | 33.55 | 87.19 |
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.
Darling Ingredients Inc develops and produces sustainable natural ingredients from edible and inedible bio-nutrients for the pharmaceutical, food, pet food, animal feed, industrial, fuel, bioenergy, and fertilizer industries. The Company collects and processes animal by-products and recycled oils into ingredients. It operates through three reportable segments: Feed Ingredients, which generates maximum revenue and includes the collection and processing of animal by-products, used cooking oil, bakery residuals, pet food ingredients, hides, and fertilizers; Food Ingredients, which includes collagen, natural casings, and food-grade fats; and Fuel Ingredients, which includes renewable fuels, biogas, and energy products. The Company derives the majority of its revenue from North America.